Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Sell
2,263
-168
-7% -$16.3K 0.04% 262
2026
Q1
$268K Hold
2,431
0.05% 230
2025
Q4
$275K Sell
2,431
-55
-2% -$6.64K 0.05% 256
2025
Q3
$360K Hold
2,486
0.07% 235
2025
Q2
$420K Buy
2,486
+100
+4% +$16.1K 0.08% 215
2025
Q1
$368K Buy
2,386
+2,380
+39,667% +$381K 0.08% 224
2024
Q4
$1.02K Hold
6
﹤0.01% 877
2024
Q3
$1.04K Hold
6
﹤0.01% 909
2024
Q2
$1.03K Hold
6
﹤0.01% 978
2024
Q1
$1.56K Hold
6
﹤0.01% 922
2023
Q4
$1.2K Hold
6
﹤0.01% 978
2023
Q3
$1.02K Hold
6
﹤0.01% 994
2023
Q2
$1.24K Hold
6
﹤0.01% 998
2023
Q1
$1.37K Hold
6
﹤0.01% 1017
2022
Q4
$1.15K Hold
6
﹤0.01% 1035
2022
Q3
$1K Hold
6
﹤0.01% 1044
2022
Q2
$1K Hold
6
﹤0.01% 1037
2022
Q1
$1K Buy
+6
New +$1.45K ﹤0.01% 985

Other funds holding NICE

Investors Research Corp's NICE Position: Q2 2026 in Review

Investors Research Corp reduced its Nice (NICE) stake by 6.9% in Q2 2026, selling an estimated $16.3K and leaving 2,263 shares worth $206K. The position accounts for 0.04% of the portfolio, ranked #262.

Investors Research Corp first reported a position in NICE in Q1 2022 and has held it in 18 quarters since. The position peaked at $420K in Q2 2025. 41 funds tracked by Wall St. Rank hold NICE as of Q2 2026.

  • Investors Research Corp held 2,263 shares of Nice worth $206K as of Q2 2026.
  • Investors Research Corp sold 168 Nice shares in Q2 2026, an estimated $16.3K.
  • Nice made up 0.04% of Investors Research Corp's portfolio in Q2 2026, its #262 holding.
  • Investors Research Corp first reported a position in Nice in Q1 2022 and has held it in 18 quarters since.
  • Investors Research Corp's Nice position peaked at $420K in Q2 2025.
  • 41 funds tracked by Wall St. Rank held Nice as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.